Literature DB >> 24857279

Optimal beam design on intensity-modulated radiation therapy with simultaneous integrated boost in nasopharyngeal cancer.

Mei-Chun Cheng1, Yu-Wen Hu2, Ching-Sheng Liu2, Jeun-Shenn Lee3, Pin-I Huang2, Sang-Hue Yen2, Yuh-Lin Lee2, Chun-Mei Hsieh2, Cheng-Ying Shiau4.   

Abstract

This study aims to determine the optimal beam design among various combinations of field numbers and beam trajectories for intensity-modulated radiation therapy (IMRT) with simultaneous integrated boost (SIB) technique for the treatment of nasopharyngeal cancer (NPC). We used 10 fields with gantry angles of 155°, 130°, 75°, 25°, 0° L, 0° R, 335°, 285°, 230°, and 205° denoted as F10. To decrease doses in the spinal cord, the F10 technique was designed by featuring 2 pairs of split-opposed beam fields at 155° to 335° and 205° to 25°, as well as one pair of manually split beam fields at 0°. The F10 technique was compared with 4 other common field arrangements: F7E, 7 fields with 50° equally spaced gantry angles; F7, the basis of F10 with 155°, 130°, 75°, 0°, 285°, 230°, and 205°; F9E, 9 fields with 40° equally spaced gantry angles; and FP, 7 posterior fields with 180°, 150°, 120°, 90°, 270°, 240°, and 210°. For each individual case of 10 patients, the customized constraints derived after optimization with the standard F10 technique were applied to 4 other field arrangements. The 4 new optimized plans of each individual case were normalized to achieve the same coverage of planning target volume (PTV)63Gy as that of the standard F10 technique. The F10 field arrangement exhibited the best coverage in PTV70Gy and the least mean dose in the trachea-esophagus region. Furthermore, the F10 field arrangement demonstrated the highest level of conformity in the low-dose region and the least monitor unit. The F10 field arrangement performed more outstandingly than the other field arrangements in PTV70Gy coverage and spared the central organ. This arrangement also exhibited the highest conformity and delivery efficiency. The F10 technique is recommended as the standard beam geometry for the SIB-IMRT of NPC.
Copyright © 2014 American Association of Medical Dosimetrists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Beam design; Intensity-modulated radiation therapy (IMRT); Nasopharyngeal cancer (NPC); Simultaneous integrated boost (SIB)

Mesh:

Year:  2014        PMID: 24857279     DOI: 10.1016/j.meddos.2014.03.003

Source DB:  PubMed          Journal:  Med Dosim        ISSN: 1873-4022            Impact factor:   1.482


  5 in total

1.  Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.

Authors:  J-Y Lu; L-L Wu; J-Y Zhang; J Zheng; M L-M Cheung; C-C Ma; L-X Xie; B-T Huang
Journal:  Br J Radiol       Date:  2014-12-12       Impact factor: 3.039

2.  Dosimetric Evaluation of a Simple Planning Technique for Improving Intensity-Modulated Radiotherapy for Nasopharyngeal Cancer.

Authors:  Jia-Yang Lu; Michael Lok-Man Cheung; Mei Li; Bao-Tian Huang; Wen-Jia Xie; Liang-Xi Xie
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

3.  Improving target coverage and organ-at-risk sparing in intensity-modulated radiotherapy for cervical oesophageal cancer using a simple optimisation method.

Authors:  Jia-Yang Lu; Michael Lok-Man Cheung; Bao-Tian Huang; Li-Li Wu; Wen-Jia Xie; Zhi-Jian Chen; De-Rui Li; Liang-Xi Xie
Journal:  PLoS One       Date:  2015-03-13       Impact factor: 3.240

4.  A simple optimization approach for improving target dose homogeneity in intensity-modulated radiotherapy for sinonasal cancer.

Authors:  Jia-Yang Lu; Ji-Yong Zhang; Mei Li; Michael Lok-Man Cheung; Yang-Kang Li; Jing Zheng; Bao-Tian Huang; Wu-Zhe Zhang
Journal:  Sci Rep       Date:  2015-10-26       Impact factor: 4.379

5.  Dosimetric evaluation of a simple planning method for improving intensity-modulated radiotherapy for stage III lung cancer.

Authors:  Jia-Yang Lu; Zhu Lin; Jing Zheng; Pei-Xian Lin; Michael Lok-Man Cheung; Bao-Tian Huang
Journal:  Sci Rep       Date:  2016-03-24       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.